Home > Share Market > Stocks > Natco pharma > Financial Statements > NATCOPHARM Key Financial Ratios

Natco pharma Financial Statements

Natco pharma Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 7.16 (12) 8.15 93.80
Op profit growth 4.05 (37) 35.90 157
EBIT growth 0.46 (35) 40.40 186
Net profit growth (4.30) (34) 43.30 209
Profitability ratios (%)        
OPM 29.50 30.40 42.50 33.80
EBIT margin 28.90 30.80 41.30 31.80
Net profit margin 21.50 24.10 31.90 24.10
RoCE 13.90 16 35 38.70
RoNW 2.79 3.37 7.37 8.25
RoA 2.58 3.12 6.75 7.31
Per share ratios ()        
EPS 24.20 25.20 37.70 27.80
Dividend per share 5.25 6.75 8.25 6.75
Cash EPS 17.80 19.80 34.10 24.80
Book value per share 226 207 167 94.60
Valuation ratios        
P/E 34 20.10 20 30.50
P/CEPS 46.40 25.50 22.10 34.20
P/B 3.65 2.44 4.53 8.95
EV/EBIDTA 21.20 13.70 14.40 21.40
Payout (%)        
Dividend payout 25.80 27.60 21.90 24.20
Tax payout (24) (19) (22) (22)
Liquidity ratios        
Debtor days 85.70 113 92.90 66.60
Inventory days 121 95 65.80 63.80
Creditor days (60) (86) (96) (89)
Leverage ratios        
Interest coverage (45) (27) (59) (35)
Net debt / equity -- 0.07 -- 0.11
Net debt / op. profit -- 0.43 -- 0.27
Cost breakup ()        
Material costs (25) (20) (19) (30)
Employee costs (20) (20) (15) (12)
Other costs (25) (30) (24) (24)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000